The pharmaceutical industry has placed a collective foot on the accelerator in the race to stem the current public health emergency, while at the same time tapping the brakes on its usual competition-based model. Pharma’s rapid and unified response to the call for novel coronavirus treatments and vaccines has highlighted the depth of the industry’s scientific and technological strength — showcasing the true potential of an industry that, in less urgent times, has been embedded with rivalries. But pharma’s successful pandemic response is only part of a much larger picture. Our “new future” will demand that the world rethinks its approach to pandemic preparedness. Click Here For Complete Article Text
|
||||||||||||||||||
| Application Sequencing | ||||||||||||||||||
|
||||||||||||||||||
| Company | Product | Process | Other Subjects | Event | Event Date | Location | Publication | Publication Date | Text Descriptor | |||||||||
|
|
|
|
|
|
|
|
|||||||||||